The FDA has approved the first at-home self-collection device for cervical cancer screening in the U.S. Patients will no ...

Based on whole-genome sequencing (WGS), the investigational test detected circulating tumor (ct)DNA with a sensitivity and ...

The American Society for Colposcopy and Cervical Pathology (ASCCP) announced new guidelines that includes extended genotyping ...

Cervical cancer is preventable, but kills thousands each year — in part because women aren't regularly screened for it. A new test allows people to test themselves at home and mail in the results.

Researchers tested the performance of the whole-genome sequencing-based assay head-to-head against ctDNA and ddPCR assays.

Pap smears have long been the standard for cervical cancer screening, but they’re no one’s idea of fun. Could this device be ...

Teal Health, the company behind the new device, hopes it will increase screening rates by making the procedure more ...

A Hong Kong-based developer of a catalog of urine-based tests for cancer, infectious diseases, women’s health and more has ...

Head and neck cancer researchers are reporting the development and testing of HPV-DeepSeek, a novel liquid biopsy assay. In their new study, HPV-DeepSeek achieved 99% sensitivty and specifity for ...

A new liquid biopsy blood test could help detect cases of human papillomavirus (HPV)-associated head and neck cancers with ...

Teal won FDA approval for a self-collection device after running a study at 16 sites in the U.S. Writing in the JAMA paper, ...

A new liquid biopsy blood test could help detect cases of human papillomavirus (HPV)-associated head and neck cancers with ...